Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Drug: Nivolumab;   Drug: Epacadostat;   Drug: Placebo;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cetuximab;   Drug: 5-Fluorouracil
Sponsors:   Incyte Corporation;   Bristol-Myers Squibb
Not yet recruiting

http://ift.tt/2zFA9qC